Imperial College London
Portrait Picture

DrVictoriaSalem

Faculty of Engineering, Department of Bioengineering

Clinical Senior Lecturer in Diabetes and Endocrinology
 
 
 
//

Contact

 

v.salem

 
 
//

Location

 

Commonwealth BuildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Salem:2010:10.1586/ecp.09.54,
author = {Salem, V and Bloom, SR},
doi = {10.1586/ecp.09.54},
journal = {Expert Rev Clin Pharmacol},
pages = {73--88},
title = {Approaches to the pharmacological treatment of obesity.},
url = {http://dx.doi.org/10.1586/ecp.09.54},
volume = {3},
year = {2010}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Obesity is a global health crisis resulting in major morbidity and premature death. The need for safe and efficacious drug therapies is great, and presently unmet. The two drugs currently licensed in the USA for the long-term treatment of obesity, orlistat and sibutramine, provide only modest weight-loss benefits and are associated with high attrition rates owing to side effects. This review summarizes current concepts in the neuroendocrine control of energy homeostasis and major pharmacological treatments for obesity in the pipeline.
AU  - Salem,V
AU  - Bloom,SR
DO  - 10.1586/ecp.09.54
EP  - 88
PY  - 2010///
SP  - 73
TI  - Approaches to the pharmacological treatment of obesity.
T2  - Expert Rev Clin Pharmacol
UR  - http://dx.doi.org/10.1586/ecp.09.54
UR  - https://www.ncbi.nlm.nih.gov/pubmed/22111534
VL  - 3
ER  -
Download